March 7, 2025 – Ottawa, ON (10 am EST)
The Stem Cell Network (SCN) and Capital BioVentures (CBV) are pleased to announce a new partnership to accelerate the development and commercialization of regenerative medicine innovations in Canada. Through this strategic collaboration emerging regenerative medicine biotechs will receive business advisory support and funding to advance their intellectual property, strengthen commercialization strategies, and attract investment.
